Back to Journals » OncoTargets and Therapy » Volume 10

Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors

Total article views   HTML views PDF downloads Totals
14,641 Dovepress* 14,023+ 1,236 15,259
PubMed Central* 618 219 837
Totals 14,641 1,455 16,096
*Since 27 June 2017
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar